Skip to search formSkip to main contentSkip to account menu

Recurrent hepatitis

National Institutes of Health

Related topics

Related topics

1 relation
Hepatitis, Chronic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The Reliability of Fibro-test in Staging Orthotopic Liver Transplant Recipients with Recurrent Hepatitis C
Abstract Background and Aims: Liver biopsy remains the gold standard for staging of chronic liver disease following orthotopic… 
2017
2017
Neuroblastoma amplified sequence gene mutation: A rare cause of recurrent liver failure in children
Neuroblastoma amplified sequence (NBAS) gene mutation or infantile liver failure syndrome type 2 (ILFS type 2) is an extremely… 
2015
2015
O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver…
2013
2013
Silibinin: an old drug in the high tech era of liver transplantation.
2011
2011
Long‐term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C
Hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (LT) is universal. We designed a retrospective case… 
Highly Cited
2007
Highly Cited
2007
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.
2006
2006
c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
Highly Cited
2005
Highly Cited
2005
MMF and Calcineurin Taper in Recurrent Hepatitis C After Liver Transplantation: Impact on Histological Course
Hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) is almost universal. The optimal… 
2003
2003
Correlation between daily cyclosporine dose and allograft injury in liver recipients with and without recurrent hepatitis C.
Review
2002
Review
2002
Treatment of recurrent hepatitis C
1 Treatment of established recurrent hepatitis C with interferon‐α monotherapy does not achieve sustained virologic response (SVR… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)